107 related articles for article (PubMed ID: 10585206)
1. Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid.
Simoni D; Invidiata FP; Rondanin R; Grimaudo S; Cannizzo G; Barbusca E; Porretto F; D'Alessandro N; Tolomeo M
J Med Chem; 1999 Dec; 42(24):4961-9. PubMed ID: 10585206
[TBL] [Abstract][Full Text] [Related]
2. Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.
Simoni D; Roberti M; Invidiata FP; Rondanin R; Baruchello R; Malagutti C; Mazzali A; Rossi M; Grimaudo S; Capone F; Dusonchet L; Meli M; Raimondi MV; Landino M; D'Alessandro N; Tolomeo M; Arindam D; Lu S; Benbrook DM
J Med Chem; 2001 Jul; 44(14):2308-18. PubMed ID: 11428925
[TBL] [Abstract][Full Text] [Related]
3. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes.
Charpentier B; Bernardon JM; Eustache J; Millois C; Martin B; Michel S; Shroot B
J Med Chem; 1995 Dec; 38(26):4993-5006. PubMed ID: 8544175
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha.
Szondy Z; Reichert U; Bernardon JM; Michel S; Tóth R; Karászi E; Fésüs L
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):767-74. PubMed ID: 9560303
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
7. Retinoidal pyrimidinecarboxylic acids. Unexpected diaza-substituent effects in retinobenzoic acids.
Ohta K; Kawachi E; Inoue N; Fukasawa H; Hashimoto Y; Itai A; Kagechika H
Chem Pharm Bull (Tokyo); 2000 Oct; 48(10):1504-13. PubMed ID: 11045459
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids.
Yu KL; Spinazze P; Ostrowski J; Currier SJ; Pack EJ; Hammer L; Roalsvig T; Honeyman JA; Tortolani DR; Reczek PR; Mansuri MM; Starrett JE
J Med Chem; 1996 Jun; 39(12):2411-21. PubMed ID: 8691435
[TBL] [Abstract][Full Text] [Related]
9. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
Makishima M; Shudo K; Honma Y
Biochem Pharmacol; 1999 Mar; 57(5):521-9. PubMed ID: 9952315
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis by retinoids and retinoic acid receptor gamma-selective compounds in mouse thymocytes through a novel apoptosis pathway.
Szondy Z; Reichert U; Bernardon JM; Michel S; Tóth R; Ancian P; Ajzner E; Fesus L
Mol Pharmacol; 1997 Jun; 51(6):972-82. PubMed ID: 9187263
[TBL] [Abstract][Full Text] [Related]
11. Differanisole A, a novel antitumor antibiotic, enhances growth inhibition and differentiation of human myeloid leukemia cells induced by 9-cis retinoic acid.
Kanatani Y; Makishima M; Asahi K; Sakurai A; Takahashi N; Motoyoshi K; Nagata N; Honma Y
Biochim Biophys Acta; 1997 Oct; 1359(1):71-9. PubMed ID: 9398087
[TBL] [Abstract][Full Text] [Related]
12. Retinoids selective for retinoid X receptor response pathways.
Lehmann JM; Jong L; Fanjul A; Cameron JF; Lu XP; Haefner P; Dawson MI; Pfahl M
Science; 1992 Dec; 258(5090):1944-6. PubMed ID: 1335166
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4.
Hashimoto Y; Kagechika H; Kawachi E; Fukasawa H; Saito G; Shudo K
Biol Pharm Bull; 1996 Oct; 19(10):1322-8. PubMed ID: 8913505
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.
Boehm MF; McClurg MR; Pathirana C; Mangelsdorf D; White SK; Hebert J; Winn D; Goldman ME; Heyman RA
J Med Chem; 1994 Feb; 37(3):408-14. PubMed ID: 8308867
[TBL] [Abstract][Full Text] [Related]
15. In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cells.
Tosi P; Pellacani A; Visani G; Ottaviani E; Ronconi S; Zamagni E; Benni M; Cavo M; Tura S
Eur J Haematol; 1999 Mar; 62(3):143-8. PubMed ID: 10089890
[TBL] [Abstract][Full Text] [Related]
16. Diphenylamine-based retinoid antagonists: regulation of RAR and RXR function depending on the N-substituent.
Ohta K; Kawachi E; Fukasawa H; Shudo K; Kagechika H
Bioorg Med Chem; 2011 Apr; 19(8):2501-7. PubMed ID: 21459577
[TBL] [Abstract][Full Text] [Related]
17. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use.
Giannini F; Maestro R; Vukosavljevic T; Pomponi F; Boiocchi M
Int J Cancer; 1997 Jan; 70(2):194-200. PubMed ID: 9009160
[TBL] [Abstract][Full Text] [Related]
18. Characterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptors.
LeMotte PK; Keidel S; Apfel CM
Biochim Biophys Acta; 1996 Mar; 1289(2):298-304. PubMed ID: 8600988
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of retinoids with novel bulky hydrophobic partial structures.
Amano Y; Noguchi M; Nakagomi M; Muratake H; Fukasawa H; Shudo K
Bioorg Med Chem; 2013 Jul; 21(14):4342-50. PubMed ID: 23685180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
